Intraocular Lens Market

• The Intraocular Lens Market is expected to rise, asserts DelveInsight.
• The leading Intraocular Lens Companies such as Johnson & Johnson Services, Inc., Hoya Corporation, ALCON INC., ZEISS Group, Rayner Intraocular Lenses Limited, Eyekon Medical Inc., Lenstec, Inc., HumanOptics AG, STAAR Surgical Company, Aurolab, PhysIOL SA, Care Group, TEKIA, Inc., Omni Lens Pvt Ltd., MORCHER® GmbH, Ophtec BV, SIFI S.p.A., Excellent Hi-Care Pvt Ltd., Bausch & Lomb Incorporated, Hanita Lens, and others.

Request for Unlocking the Sample Page of the "Intraocular Lens Market"

Intraocular Lens Market by Type (Monofocal IOL (Aspheric Monofocal IOLs and Spheric Monofocal IOLs), Premium IOLs (Multifocal IOLs, Accommodating IOLs, and Extended Depth-Of-Focus (EDoF) IOLs), and Others), Intraocular Lens Market by Material (Polymethyl Methacrylate (PMMA), Hydrophobic Acrylic IOLs, Hydrophilic Acrylic IOLs, and Others), Intraocular Lens Market by End-User (Hospitals, Ambulatory Surgical Centres, and Ophthalmology Clinics), and Intraocular Lens Market by Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to grow at a steady CAGR forecast till 2032 owing to growing cases of eye-related disorders, increased awareness and accessibility to eye care, technological advancements in lens materials and designs, and increase in product development activities among the key Intraocular Lens Companies.

The Global Intraocular Lens Market was valued at USD 4,648.96 million in 2024, growing at a CAGR of 6.12% during the forecast period from 2025 to 2032 to reach USD 7,414.66 million by 2032. The intraocular lens market is being significantly boosted by the growing cases of eye-related disorders such as cataracts, presbyopia, and astigmatism, which are increasing the demand for corrective surgical interventions. This rising disease burden is complemented by improved awareness and accessibility to eye care services, especially in developing regions, enabling more patients to seek treatment. Additionally, ongoing technological advancements in lens materials and designs such as the development of multifocal, toric, and extended depth-of-focus lenses are enhancing visual outcomes and patient satisfaction. Furthermore, increased product development activities by key market players are leading to the introduction of innovative and customized IOL solutions, collectively accelerating the growth of the global intraocular lens market during the forecast period from 2025 to 2032. 

Intraocular Lens Market Dynamics

According to Vision Center (2024), currently, late teenagers and young adults in countries like Korea, Taiwan, and China suffer from Myopia Prevalence rates ranging from 84% to 97% on average. Globally, approximately 224 million individuals, constituting nearly 3% of the population, suffer from severe myopia. The projections for 2050 are more alarming, with almost half of the world's population, constituting 5 billion people expected to be myopic. The prevalence of high myopia is anticipated to elevate for almost 10% of the global population by 2050, translating to around 1 billion individuals at risk of permanent vision impairment. The global condition of myopia, or near-sightedness, is affecting millions and is on the rise due to trends in urbanization and digitalization.

Thus, the rising global Myopia Prevalence, particularly high myopia, is significantly driving demand for intraocular lenses (IOLs). As more individuals face vision impairment at younger ages, the need for advanced corrective solutions like IOLs is increasing. This trend is further amplified by lifestyle factors such as increased screen time and urban living, prompting earlier interventions. In response, the ophthalmic industry is expanding its offerings, with IOLs becoming a key solution for long-term vision correction, especially in cases where traditional eyewear or contact lenses are insufficient.

Furthermore, government initiatives aimed at enhancing eye health, coupled with advancements in ophthalmology technology, are further driving the market growth. For instance, in August 2022, The International Agency for the Prevention of Blindness (IAPB), launched a global awareness campaign by emphasizing the importance of eye care, for approximately 1 billion people worldwide lacking access to treatment for poor vision.

Additionally, the increase in strategic activities among the key market players is further escalating the market for the same. For example, in May 2025, Eye health company Bausch + Lomb received CE Mark approval in Europe for its LuxLife range of intraocular lenses (IOLs), marking a key milestone in expanding its vision correction portfolio. Despite these promising growth factors, the intraocular lens market faces challenges. Post-operative complications associated with an intraocular lens, and lack of coverage of premium lenses among others are significant constraints that could potentially hinder market growth during the forecast period.

Intraocular Lens Market Segment Analysis

Intraocular Lens Market by Type (Monofocal IOL (Aspheric Monofocal IOLs and Spheric Monofocal IOLs), Premium IOLs (Multifocal IOLs, Accommodating IOLs, and Extended Depth-Of-Focus (EDoF) IOLs), and Others), Intraocular Lens Market by Material (Polymethyl Methacrylate (PMMA), Hydrophobic Acrylic IOLs, Hydrophilic Acrylic IOLs, and Others), Intraocular Lens Market by End-User (Hospitals, Ambulatory Surgical Centres and Ophthalmology Clinics), and Intraocular Lens Market by Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the premium IOLs segment of the intraocular lens market, the Extended Depth of Focus category is projected to capture a significant revenue share in 2024. Extended Depth of Focus (EDOF or EDF), or Extended Range of Vision, is a new technology that has recently emerged in the treatment of Presbyopia-correcting IOLs and works by creating a single elongated focal point to enhance “range of vision” or “depth of focus”.

EDOF lenses have been shown to increase levels of spectacle independence but may be associated with unwanted photic phenomena such as glare and halos. These lenses demonstrate high levels of patient satisfaction and, thus, are expected to drive market growth in the coming years. These lenses are related to high focus and provide more range than a monofocal IOL. Additionally, in May 2025, Alcon, the global leader in eye care committed to helping people see brilliantly, announced that its Vivity® intraocular lens, the most widely implanted extended depth of focus (EDOF) IOL, which is now available on its most advanced lens material, Clareon®. The Clareon Vivity® received CE Mark approval and is set to begin commercial rollout across Europe in early Q2 2025.

Given these factors, the Extended Depth-Of-Focus category is expected to witness robust growth during the forecast period, thereby driving the overall expansion of the intraocular lens market.

North America is expected to dominate the overall Intraocular Lens market:

North America's Intraocular lens market is projected to account for the largest share of the intraocular lens market in 2024. This is driven by the presence of a significant number of eye care professionals and clinics, including optometrists, ophthalmologists, and eye care centers, a large patient pool associated with vision loss, hypermetropia, and astigmatism, the presence of a developed & sophisticated healthcare infrastructure, and product developmental activities are factors that drive the expansion of the intraocular lens market in the North America region during the forecast period from 2025 to 2032.

According to the American Academy of Ophthalmology (2024), 33% of people in the US have astigmatism. Astigmatism affects people of all ages and races. Babies may even have astigmatism, although most soon outgrow it. Additionally, it stated that 14 million Americans aged 40 and above are affected with hypermetropia. Astigmatism is a common refractive error caused by an irregular curvature of the cornea or lens, leading to blurred or distorted vision at all distances. As more patients seek comprehensive vision correction along with cataract treatment, the preference for advanced lenses that address astigmatism has grown.

Additionally, according to statistics unveiled by the Canadian Council of the Blind (2022), approximately 1.2 million Canadians suffered vision loss in 2020. Projections for the year 2030 estimate that this figure will surge to 1.58 million. Such an increase in the number of cases of vision impairment is anticipated to fuel the uptake of visual impairment devices, consequently influencing market dynamics in the region. As awareness of eye health grows in response to the rising prevalence of vision loss, there may be a greater emphasis on preventive care and early detection of eye conditions.

The increasing incidence of vision conditions such as astigmatism, hypermetropia, and overall visual impairment is significantly boosting the demand for intraocular lenses (IOLs). As public awareness of eye health grows, more individuals are opting for corrective procedures to improve or restore their vision, particularly through cataract and refractive surgeries. This rising demand, combined with technological advancements in lens design and a stronger emphasis on early detection and preventive eye care, is driving steady growth in the IOL market.

Additionally, rising product developmental activities by regulatory bodies and key players in the region will further boost the market for intraocular lenses. For example, in October 2024, Johnson & Johnson (J&J), a leader in eye health solutions, announced the expanded availability of its TECNIS Odyssey intraocular lens (IOL) across the United States.

Intraocular Lens Companies

The leading Intraocular Lens Companies such as Johnson & Johnson Services, Inc., Hoya Corporation, ALCON INC., ZEISS Group, Rayner Intraocular Lenses Limited, Eyekon Medical Inc., Lenstec, Inc., HumanOptics AG, STAAR Surgical Company, Aurolab, PhysIOL SA, Care Group, TEKIA, Inc., Omni Lens Pvt Ltd., MORCHER® GmbH, Ophtec BV, SIFI S.p.A., Excellent Hi-Care Pvt Ltd., Bausch & Lomb Incorporated, Hanita Lens, and others.

Recent Developmental Activities in the Intraocular Lens Market:

• In October 2024, Bausch + Lomb Corporation, a leading global eye health company committed to helping people improve their vision for a better quality of life, announced that the U.S. Food and Drug Administration approved the enVista® Envy™ full range of vision intraocular lens (IOL).
• In July 2022, Apthera™ Intraocular Lens (IOL) received FDA approval, marking several significant industry firsts. It is the first small aperture IOL to gain FDA approval, the first lens approved for implantation alongside a monofocal or monofocal toric IOL in the fellow eye, and the first extended depth of focus (EDOF) lens indicated for monovision. Additionally, it is the first non-toric IOL approved for cataract patients with low levels of corneal astigmatism, representing a major advancement in personalized cataract treatment.

Key Takeaways from the Intraocular Lens Market Report Study

• Intraocular Lens Market Size analysis for current intraocular lens market size (2024), and market forecast for 8 years (2025 to 2032)
• Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures happened over the last 3 years.
• Key Intraocular Lens Companies dominating the intraocular lens market.
• Various opportunities available for the other competitors in the intraocular lens market space.
• What are the top-performing segments in 2024? How these segments will perform in 2032?
• Which are the top-performing regions and countries in the current intraocular lens market scenario?
• Which are the regions and countries where Intraocular Lens Companies should have concentrated on opportunities for intraocular lens market growth in the coming future?

Target Audience Who Can be benefited from this Intraocular Lens Market Report Study

• Intraocular lens product providers
• Research organizations and consulting Intraocular Lens Companies 
• Intraocular Lens-related organizations, associations, forums, and other alliances
• Government and corporate offices
• Start-up intraocular lens companies, venture capitalists, and private equity firms
• Distributors and traders dealing in Intraocular Lens   
• Various end-users who want to know more about the intraocular lens market and the latest technological developments in the intraocular lens market.  

Stay updated with us for Recent Articles

• Global Top Players in the Intraocular Lens (IOL) Market
• Latest DelveInsight Blogs